Table 2: Clinical characteristics of patients with positive GDH test only

Patient no / Sex Age / Hospital / Basic disease / Hospitalization in previous 3 months / CDI in previous 8 weeks / Onset of symptoms / ICU admission / Comorbidities / Fever / Stool count / Leucocyte count (109/L) / Pseudomembranes / Antibiotic use in previous 3 months / Antibiotic treatment / Death / PCR-ribotype
23 / F/81 / D / Pneumonia / yes / 48 hrs / yes / yes / 3 / 6.65 / AMP, AMC, CTX, CIP / yes
24 / F/90 / D / Stroke / yes / 48 hrs / yes / 4 / 21.2 / 001
25 / M/72 / D / Diabetes mellitus, Gastric carcinoma / yes / 48 hrs / yes / 3 / 6.77 / CIP
26 / M/77 / F / Heart disease / yes / 48 hrs / 8 / 10.6 / CTX / MTZ oral
27 / F/81 / E / Sepsis / yes / 48 hrs / yes / yes / >38ºC / 4 / 8.4 / CFX, CIP / MTZ oral and iv
28 / F/69 / E / Pneumonia / yes / 48 hrs / yes / >38ºC / 7 / 11.2 / AMS / VA and MTZ oral / 001
29 / M/72 / A / Dehydration / 48 hrs / 2 / 6.9 / CIP / 001
30 / F/82 / C / Alzheimer disease / yes / 6 / 18.03 / unspecified / MTZ oral / 001
31 / M/21 / F / Ulcerative colitis / 2 / 3.2 / 001
32 / F/74 / A / Spondylodiscitis / yes / yes / 48 hrs / 5 / 5.14 / CIP, glycopeptide, RIF / VA and MTZ iv / 017

AMC-Amoxicillin-clavulanic acid; AMP-Ampicillin; AMS-Ampicillin-sulbactam; CFX-Cefuroxime; CIP-Ciprofloxacin; CLI-Clindamycin; CL-Colistin; CPS-Cefoperazone sulfbactam; CTR- Ceftriaxone; CTX-Cefotaxime; MTZ-Metronidazole; RIF-Rifampicin; VA-Vancomycin.